BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32938850)

  • 21. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus.
    Kudolo GB
    J Clin Pharmacol; 2001 Jun; 41(6):600-11. PubMed ID: 11402628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the metabolic effects of mixed meal and standard oral glucose tolerance test on glucose, insulin and C-peptide response in healthy, impaired glucose tolerance, mild and severe non-insulin-dependent diabetic subjects.
    Marena S; Montegrosso G; De Michieli F; Pisu E; Pagano G
    Acta Diabetol; 1992; 29(1):29-33. PubMed ID: 1520903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of standard test meal in initiation of insulin therapy in type 2 diabetes].
    Koprivica B; Beljić-Zivković T; Ille T
    Srp Arh Celok Lek; 2009; 137(9-10):490-6. PubMed ID: 19950754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of poorly controlled non-insulin-dependent diabetic patients with Acarbose.
    Scott RS; Knowles RL; Beaven DW
    Aust N Z J Med; 1984 Oct; 14(5):649-54. PubMed ID: 6397178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests.
    Deng Y; Zhang Y; Zheng S; Hong J; Wang C; Liu T; Sun Z; Gu W; Gu Y; Shi J; Yao S; Wang W; Ning G
    J Diabetes; 2015 Nov; 7(6):820-9. PubMed ID: 25395350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.
    Gredal C; Rosenfalck AM; Dejgaard A; Hilsted J
    Scand J Clin Lab Invest; 2007; 67(3):327-36. PubMed ID: 17454847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is type 2 diabetes a different disease in obese and nonobese patients?
    Prando R; Cheli V; Melga P; Giusti R; Ciuchi E; Odetti P
    Diabetes Care; 1998 Oct; 21(10):1680-5. PubMed ID: 9773730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of nateglinide on the elevation of postprandial remnant-like particle triglyceride levels in Japanese patients with type 2 diabetes assessment by meal tolerance test.
    Mori Y; Kuriyama G; Tajima N
    Endocrine; 2004 Dec; 25(3):203-6. PubMed ID: 15758246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum bilirubin concentrations are positively associated with serum C-peptide levels in patients with Type 2 diabetes.
    Chung JO; Cho DH; Chung DJ; Chung MY
    Diabet Med; 2014 Nov; 31(11):1316-22. PubMed ID: 24910105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
    Maggs DG; Buchanan TA; Burant CF; Cline G; Gumbiner B; Hsueh WA; Inzucchi S; Kelley D; Nolan J; Olefsky JM; Polonsky KS; Silver D; Valiquett TR; Shulman GI
    Ann Intern Med; 1998 Feb; 128(3):176-85. PubMed ID: 9454525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-peptide index at 2 h post-meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes.
    Iwamoto Y; Kimura T; Shimoda M; Morimoto Y; Watanabe Y; Itoh T; Sasaki T; Mori S; Kubo M; Takenouchi H; Dan K; Iwamoto H; Sanada J; Fushimi Y; Katakura Y; Nakanishi S; Mune T; Kaku K; Kaneto H
    Diabetes Obes Metab; 2024 Jul; 26(7):2761-2773. PubMed ID: 38646845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
    Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
    Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed-meal tolerance test to assess residual beta-cell secretion: Beyond the area-under-curve of plasma C-peptide concentration.
    Ruan Y; Willemsen RH; Wilinska ME; Tauschmann M; Dunger DB; Hovorka R
    Pediatr Diabetes; 2019 May; 20(3):282-285. PubMed ID: 30652426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
    Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T
    Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Jones IR; Owens DR; Luzio S; Williams S; Hayes TM
    Diabetologia; 1989 Sep; 32(9):668-77. PubMed ID: 2676668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C-peptide immunoreactivity.
    Fujioka Y; Okura T; Sumi K; Matsumoto K; Shoji K; Nakamura R; Matsuzawa K; Izawa S; Kato M; Taniguchi S; Yamamoto K
    J Diabetes Investig; 2018 Mar; 9(2):274-278. PubMed ID: 28494143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in circulating adiponectin, leptin, glucose and C-peptide in patients with ketosis-prone diabetes.
    Gupta P; Liu Y; Lapointe M; Yotsapon T; Sarat S; Cianflone K
    Diabet Med; 2015 May; 32(5):692-700. PubMed ID: 25407468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postprandial metabolic responses to mixed versus liquid meal tests in healthy men and men with type 2 diabetes.
    Brodovicz KG; Girman CJ; Simonis-Bik AM; Rijkelijkhuizen JM; Zelis M; Bunck MC; Mari A; Nijpels G; Eekhoff EM; Dekker JM
    Diabetes Res Clin Pract; 2011 Dec; 94(3):449-55. PubMed ID: 21955958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic beta-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus.
    Hovorka R; Chassin L; Luzio SD; Playle R; Owens DR
    J Clin Endocrinol Metab; 1998 Mar; 83(3):744-50. PubMed ID: 9506719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [2h-CPR/2h-PG in 75g-OGTT].
    Onouchi Z; Kunimaru S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():394-9. PubMed ID: 15779411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.